FLT4 and kidney neoplasm: Furthermore, metastases from kidney tumors still showed high expression levels of VEGFR-3 after treatment with the RTK inhibitor sunitinib (Fig. 2E), suggesting that EVT801 administration may also be warranted after failure of other RTK inhibitors.